Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States (vol 40, pg 3543, 2023)

被引：0
|
作者：
Udeze, Chuka [1 ]
Evans, Kristin A. [2 ]
Yang, Yoojung [1 ]
Lillehaugen, Timothy [2 ]
Manjelievskaia, Janna [2 ]
Mujumdar, Urvi [1 ]
Li, Nanxin [1 ]
Andemariam, Biree [3 ]
机构：
[1] Vertex Pharmaceut Inc, Boston, MA USA
[2] Merative, Cambridge, MA USA
[3] Univ Connecticut Hlth, Div Hematoloncol, 263 Farmington Ave, Farmington, CT 06030 USA
来源：
ADVANCES IN THERAPY | 2023年 / 40卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
下载
收藏
页码：5130 / 5130
页数：1
相关论文
共 50 条
  • [1] Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States( vol 40 , 3543 , 2023)
    Udeze, Chuka
    Evans, Kristin A.
    Yang, Yoojung
    Lillehaugen, Timothy
    Manjelievskaia, Janna
    Mujumdar, Urvi
    Li, Nanxin
    Andemariam, Biree
    ADVANCES IN THERAPY, 2023,
  • [2] Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
    Chuka Udeze
    Kristin A. Evans
    Yoojung Yang
    Timothy Lillehaugen
    Janna Manjelievskaia
    Urvi Mujumdar
    Nanxin Li
    Biree Andemariam
    Advances in Therapy, 2023, 40 : 3543 - 3558
  • [3] Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
    Udeze, Chuka
    Evans, Kristin A.
    Yang, Yoojung
    Lillehaugen, Timothy
    Manjelievskaia, Janna
    Mujumdar, Urvi
    Li, Nanxin
    Andemariam, Biree
    ADVANCES IN THERAPY, 2023, 40 (08) : 3543 - 3558
  • [4] Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
    Chuka Udeze
    Kristin A. Evans
    Yoojung Yang
    Timothy Lillehaugen
    Janna Manjelievskaia
    Urvi Mujumdar
    Nanxin Li
    Biree Andemariam
    Advances in Therapy, 2023, 40 : 5130 - 5130
  • [5] MODELLING LONG-TERM CLINICAL OUTCOMES OF PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN THE UNITED STATES
    Wang, J.
    Udeze, C.
    Ogunsile, F. J.
    Xie, Y.
    Mujumdar, U.
    Yang, H.
    Salcedo, J.
    Lopez, A.
    VALUE IN HEALTH, 2022, 25 (12) : S91 - S91
  • [6] Clinical complications among patients with sickle cell disease with recurrent vaso-occlusive crises in Germany
    Tuzin, P.
    Udeze, C.
    Kunzweiler, C.
    Li, N.
    Baldwin, J.
    Barth, S. D.
    Vetter, C.
    Dombrowski, S.
    Georgiadou-Schmidt, E.
    Meisel, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 300 - 301
  • [7] Sickle Cell Disease and Pain Is it all Vaso-occlusive Crises?
    Ramsay, Zachary
    Bartlett, Rachel
    Ali, Amza
    Grant, Justin
    Gordon-Strachan, Georgiana
    Asnani, Monika
    CLINICAL JOURNAL OF PAIN, 2021, 37 (08): : 583 - 590
  • [8] Sickle cell disease in children: Osteomyelitis or vaso-occlusive crises?
    Berger, Elizabeth
    Saunders, Natasha
    Khambalia, Amina
    Friedman, Jeremy N.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 612 - 612
  • [9] Crizanlizumab approved in Europe for Prevention of recurrent vaso-occlusive Crises in Sickle Cell Disease
    不详
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2021, 48 (01) : 69 - 69
  • [10] MORTALITY AND CLINICAL COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN FRANCE
    Baldwin, J.
    Udeze, C.
    Li, N.
    Boulmerka, L.
    Dahal, L.
    Pesce, G.
    Quignot, N.
    Jiang, H.
    Galacteros, F.
    VALUE IN HEALTH, 2023, 26 (12) : S47 - S47
12345